We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.53B
AUM Growth
-$705M
Cap. Flow
-$541M
Cap. Flow %
-15.35%
Top 10 Hldgs %
57.42%
Holding
95
New
5
Increased
17
Reduced
31
Closed
5

Top Buys

Rank Stock Value
1
WB icon
Weibo
WB
+$107M
2
RIG icon
Transocean
RIG
+$71.8M
3
MCHP icon
Microchip Technology
MCHP
+$47.3M
4
HCC icon
Warrior Met Coal
HCC
+$39.8M
5
BIDU icon
Baidu
BIDU
+$28.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$226M
2
SLB icon
SLB Ltd
SLB
+$122M
3
INTC icon
Intel
INTC
+$79M
4
GILD icon
Gilead Sciences
GILD
+$77.5M
5
MLCO icon
Melco Resorts & Entertainment
MLCO
+$56.3M

Sector Composition

Rank Sector Weight
1 Communication Services 27.27%
2 Energy 15.69%
3 Industrials 12.55%
4 Technology 11.17%
5 Healthcare 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
51
Oracle
ORCL
$423B
$2.14M 0.06%
41,500
-9,000
-18% -$437K
MRUS
52
DELISTED
Merus
MRUS
$2.02M 0.06%
102,219
AERI
53
DELISTED
Aerie Pharmaceuticals
AERI
$1.95M 0.06%
31,700
-5,900
-16% -$379K
MYOV
54
DELISTED
Myovant Sciences Ltd.
MYOV
$1.9M 0.05%
71,400
+17,200
+32% +$389K
CCL icon
55
Carnival Corporation Ltd
CCL
$39.7B
$1.87M 0.05%
29,260
COGT icon
56
Cogent Biosciences
COGT
$7.24B
$1.81M 0.05%
43,925
-12,325
-22% -$695K
PRTA icon
57
Prothena Corp
PRTA
$450M
$1.77M 0.05%
135,200
CSCO icon
58
Cisco
CSCO
$479B
$1.74M 0.05%
35,700
FPRX
59
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.69M 0.05%
121,576
+27,376
+29% +$407K
ZLAB icon
60
Zai Lab
ZLAB
$2.62B
$1.64M 0.05%
84,250
+64,250
+321% +$1.39M
WVE icon
61
Wave Life Sciences
WVE
$1.2B
$1.61M 0.05%
32,200
NTLA icon
62
Intellia Therapeutics
NTLA
$1.67B
$1.57M 0.04%
55,000
INCY icon
63
Incyte
INCY
$24.4B
$1.45M 0.04%
20,964
BMRN icon
64
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.34M 0.04%
13,820
RCUS icon
65
Arcus Biosciences
RCUS
$3.64B
$1.34M 0.04%
95,841
+43,000
+81% +$548K
MRK icon
66
Merck
MRK
$318B
$1.33M 0.04%
19,702
PRGO icon
67
Perrigo
PRGO
$1.78B
$1.32M 0.04%
18,700
+8,000
+75% +$601K
LRCX icon
68
Lam Research
LRCX
$390B
$1.29M 0.04%
85,200
+18,200
+27% +$311K
DERM
69
DELISTED
Dermira, Inc.
DERM
$1.27M 0.04%
116,325
+53,425
+85% +$539K
IRWD icon
70
Ironwood Pharmaceuticals
IRWD
$714M
$1.27M 0.04%
81,908
-14,448
-15% -$228K
RTX icon
71
RTX Corp
RTX
$301B
$1.12M 0.03%
12,712
PVLA
72
Palvella Therapeutics
PVLA
$2.27B
$1.08M 0.03%
2,401
+848
+55% +$369K
EBAY icon
73
eBay
EBAY
$49.8B
$1.01M 0.03%
30,700
TRIL
74
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.01M 0.03%
175,339
JD icon
75
JD.com
JD
$44.5B
$934K 0.03%
35,800
-976,642
-96% -$32M

Similar funds

Platinum Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Platinum Investment Management held 95 positions worth $3.53B, down 17% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Platinum Investment Management withdrew a net $541M in Q3 2018, closing 5 positions and reducing 31 holdings. Its most notable exit was SLB Ltd, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 27% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.

Against the trend, Platinum Investment Management opened a new position in The Stars Group Inc. worth $16.7M.

  • Platinum Investment Management's largest Q3 2018 buy was The Stars Group Inc.: 669,529 shares worth $16.7M.
  • Platinum Investment Management added most to Weibo in Q3 2018, an estimated $107M increase.
  • Platinum Investment Management's biggest Q3 2018 reduction was Alibaba, cutting an estimated $226M.
  • Platinum Investment Management fully exited SLB Ltd in Q3 2018, selling an estimated $122M.
  • Platinum Investment Management's ten largest holdings make up 57% of its $3.53B portfolio in Q3 2018.
  • Platinum Investment Management opened 5 new positions and closed 5 in Q3 2018.
  • Platinum Investment Management's portfolio value fell 17% quarter-over-quarter to $3.53B.

Based on Platinum Investment Management's 13F filing for Q3 2018, filed 15 Nov 2018.